Today on Outsourcing-Pharma.com   Clinical staffing a 'tremendous problem' Excipients unregulated and unacceptable Pharmaceuticals is top R&D spender UK innovation to get billion pound boost CPhI show: news in brief

Related Industry News   Three more nailed in fake drugs scandal Investors jump into PDL stock in hope of imminent buyout Granulation technology launched Sperm stopped in their tracks by vaginal gel contraceptive

Breaking News on Outsourcing Pharma
Daily  Monday 08 October 2007		Forward to a colleague

	Sponsored Link Introducing Catalent Pharma Solutions Catalent Pharma Solutions is the leading provider of advanced technologies as well as development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer health companies in nearly 100 countries... Click Here Access Full Stories Clinical staffing a 'tremendous problem' The European clinical trials industry is experiencing a "tremendous problem" with staff recruitment - salaries are climbing as a result... Read Excipients unregulated and unacceptable The European Fine Chemicals Group (EFCG) has called for stricter regulation of pharmaceutical excipients in a bid to prevent substandard and potentially dangerous products ending up in medicinal drugs... Read Pharmaceuticals is top R&D spender As an increasingly desperate pharma industry strives to fill drug pipelines, the sector has, for the first time, topped a poll of which industries spend the most on research and development... Read UK innovation to get billion pound boost The UK government has set-aside £1bn (€1.45bn) to give early-stage companies better support after a review of the UK's science and innovation policies by Lord Sainsbury of Turville... Read CPhI show: news in brief Pharmaceutical manufacturers were in full force at this year's CPhI trade show held in Milan, where several new company announcements were made... Read
	All News Headlines for: October | September | August
	Product Brochure Baxter's contract services case study Baxter's contract services case study details the expedited transfer of a commercial launched lyophilized drug to a new production site. Their team designed solutions resulting in cost savings, yield improvement and cycle optimization... Click Here
	Related Industry News Three more nailed in fake drugs scandal Three more individuals have been sentenced following last month's exposure of the largest counterfeit drugs conspiracy ever to be encountered in the UK... Read Investors jump into PDL stock in hope of imminent buyout Furious trading in shares of PDL BioPharma has taken place over the past couple of days as investors jumped in with both pockets open in the hope that a partner will soon be in the offing for the ailing firm... Read Granulation technology launched Finland-based Atacama Labs has launched its proprietary technology system for developing solid oral dosage forms... Read Sperm stopped in their tracks by vaginal gel contraceptive Forget diamonds, a new vaginal gel contraceptive could be the 21st Century girl's new best friend with the ability to be applied up to 18 hours before a naughty rendezvous... Read Weekly Comment FDA told its safety monitoring of clinical trials not good enough The US Food and Drug Administration (FDA) has been called into question again after the release of a damning report, this time suggesting the agency is inadequate in its safety monitoring of clinical trials. Read Previous Headlines Genzyme gets slapped on the wrist by FDA The US Food and Drug Administration (FDA) has sent a letter to Genzyme to warn it about manufacturing issues at its biomanufacturing facility in Lyon, France... Read Bayer, Biocon discuss potential R&D and outsourcing deal German pharma firm Bayer is currently discussing with Indian company Biocon about a potential deal that would include the co-development of new biologics with an outsourcing element, according to Biocon... Read Eli Lilly: drug safety revolution 'within our grasp' The head of Eli Lilly has called for a reform of the US drug safety system, saying that an information revolution is 'within our grasp'... Read Big pharma enters stem cell domain to address safety, attrition Three of the world's biggest pharmaceutical companies have signed a landmark deal with the UK government that will see them use stem cell technology to road-test the safety of new compounds... Read CRO supremacy in clinical research raises concerns While contract research organisations (CROs) now dominate the clinical trials market, questions are being raised about the risks of 'commercialising' clinical studies, according to new research... Read Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com